Stocks  /  NASDAQ  /  Alumis Inc.

Alumis Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   ALMSNASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Alumis Inc. is a clinical-stage biopharmaceutical company. As part of its drug development process, the company conducts preclinical studies, which involve animal testing, to evaluate the safety and efficacy of its therapeutic candidates before they are tested in human clinical trials.

Exact Quote from Link: “Additionally, a microdialysis study in rats demonstrated the ability of A-005 to efficiently cross the blood brain barrier.”

Link: https://investors.alumis.com/news-releases/news-release-details/alumis-presents-preclinical-data-allosteric-tyk2-inhibitor-005/

Company Description

Scroll to Top